Tempus
In Brief This Week: Burning Rock Biotech, Biocartis, NYGC, Eagle Genomics, Theradiag, OpGen, More
News items for the week of Jan. 16, 2023.
Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer
This clinical study, called Sculptor, is the first research to emerge from a strategic collaboration between the companies on oncology therapeutics.
In Brief This Week: OpGen, MDxHealth, Dante Genomics, More
New items for the week of Oct. 24, 2022.
Tempus, Kartos Therapeutics to Develop CDx for Skin Cancer Therapy
The test will run on Tempus' xT platform and will be used to identify patients with TP53 wild-type Merkel cell carcinoma who may be eligible for treatment with the drug.
Tempus, Children's Oncology Group Expand Genomic Testing Access for Pediatric Cancer Patients
Tempus' xT platform will be used to identify patients likely to match for a trial assessing the efficacy of genetically informed treatments in certain pediatric cancers.